|
Volumn 21, Issue 7, 2013, Pages 514-518
|
[Supplemental Fuzhenghuayu capsule therapy for improving liver fibrosis markers in patients with chronic hepatitis B following unsatisfactory outcome of nucleos(t)ide analogue monotherapy]
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
FUZHENG HUAYU;
HERBACEOUS AGENT;
NUCLEOTIDE;
ADULT;
CONTROLLED STUDY;
FEMALE;
HEPATITIS B, CHRONIC;
HUMAN;
LIVER;
LIVER CIRRHOSIS;
MALE;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PHYTOTHERAPY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
DRUGS, CHINESE HERBAL;
FEMALE;
HEPATITIS B, CHRONIC;
HUMANS;
LIVER;
LIVER CIRRHOSIS;
MALE;
MIDDLE AGED;
NUCLEOTIDES;
PHYTOTHERAPY;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 84921050872
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: 10.3760/cma.j.issn.1007-3418.2013.07.010 Document Type: Article |
Times cited : (5)
|
References (0)
|